Anatomical and functional imaging of tumors in animal models: Focus on pheochromocytoma

Annals of the New York Academy of Sciences

Volumn 1073, Issue , 2006, Pages 392-404

  Martiniova, Lucia ^a   Ohta, Shoichiro ^a   Guion, Peter ^b   Schimel, Daniel ^c   Lai, Edwin W ^a   Klaunberg, Brenda ^c   Jagoda, Elaine ^d   Pacak, Karel ^a,e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Anatomical imaging; Animal model; Functional imaging; Pheochromocytoma; 18F 6F dopamine

Indexed keywords

CONTRAST MEDIUM; FENESTRA; FLUORODOPA F 18; FLUORODOPAMINE F 18; HORMONE RECEPTOR; NORADRENALIN TRANSPORTER; RADIOPHARMACEUTICAL AGENT;

BIOLUMINESCENCE; CANCER MODEL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ENDOCRINE TUMOR; FUNCTIONAL ANATOMY; HORMONE RELEASE; HORMONE SYNTHESIS; HORMONE TRANSPORT; IMAGING SYSTEM; METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; TUMOR CELL; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

ANIMALIA;

EID: 33845497241     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1353.043     Document Type: Conference Paper

References (42)

1. WEISSLEDER, R. & U. MAHMOOD. 2001. Molecular imaging. Radiology 219: 316-333.
2. BUDINGER, T.F., D.A. BENARON & A.P. KORETSKY. 1999. Imaging transgenic animals. Annu. Rev. Biomed. Eng. 1: 611-648.
3. THIEL, A. et al. 1998. Localization of language-related cortex with 15O-labeled water PET in patients with gliomas. Neuroimage 7: 284-295.
4. BLANKENBERG, F.G. et al. 2000. Apoptosis: the importance of nuclear medicine. Nucl. Med. Commun. 21: 241-250.
5. VAALBURG, W. et al. 1992. Amino acids for the measurement of protein synthesis in vivo by PET. Int. J. Rad. Appl. Instrum. B. 19: 227-237.
6. WILLEMSEN, A.T. et al. 1995. In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[111C]-tyrosine and PET. J. Nucl. Med. 36: 411-419.
7. LEWIS, J.S. & M.J. WELCH. 2001. PET imaging of hypoxia. Q. J. Nucl. Med. 45: 183-188.
8. HAUBNER, R. et al. 2001. Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res. 61: 1781-1785.
9. COSTOUROS, N.G., F.E. DIEHN & S.K. LIBUTTI. 2002. Molecular imaging of tumor angiogenesis. J. Cell. Biochem. Suppl. 39: 72-78.
10. GRIERSON, J.R. & A.F. SHIELDS. 2000. Radiosynthesis of 3′-deoxy-3′-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo. Nucl. Med. Biol. 27: 143-156.
11. CORLETO, V.D. et al. 1996. Somatostatin receptor localization of pancreatic endocrine tumors. World J. Surg. 20: 241-244.
12. PACAK, K. et al. 2001. 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38: 6-8.
13. CHUNG, J.K. et al. 1999. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J. Nucl. Med. 40: 986-992.
14. PACAK, K. et al. 2001. Pheochromocytoma: progress in diagnosis, therapy, and genetics. In Adrenal Disorders, Vol. 1. A. Margioris & G.P. Chrousos, Eds.: 479-523. Humana Press. Totowa, NJ.
15. TISCHLER, A.S., J.F. POWERS & J. ALROY. 2004. Animal models of pheochromocytoma. Histol. Histopathol. 19: 883-895.
16. BORAH, B. et al. 2001. Three-dimensional microimaging (MRmicroI and microCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis. Anat. Rec. 265: 101-110.
17. LEWIS, J.S. et al. 2002. Small animal imaging current technology and perspectives for oncological imaging. Eur. J. Cancer 38: 2173-2188.
18. WEBER, S.M. et al. 2004. Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement. J. Surg. Res. 119: 41-45.
19. SEIDEL, J. 2002. Features of the NIH ATLAS small animal PET scanner and its use with a coaxial small animal volume CT scanner. Proc IEEE International Symposium on Biomedical Imaging (ISBI'02) TP-P14: 545-548.
20. SCHODER, H., S.M. LARSON & H.W. YEUNG. 2004. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J. Nucl. Med. 45(Suppl. 1): 72S-81S.
21. WAHL, R.A. 2004. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J. Nucl. Med. 45: 82S-95S.
22. FAYAD, Z.A. et al. 1998. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation 98: 1541-1547.
23. BALABAN, R.S. & V.A. HAMPSHIRE. 2001. Challenges in small animal noninvasive imaging. ILAR J. 42: 248-262.
24. DU, W. et al. 2005. Comparison of high-resolution echo-planar spectroscopic imaging with conventional MR imaging of prostate tumors in mice. NMR Biomed. 18: 285-292.
25. HANSJO, G. 2003. Inductively coupled rf coils for examinations of small animals and objects in Standard whole-body MR scanners. Med. Phys. 30: 1241-1245.
26. PAWELKE, B. 2005. Metabolite analysis in positron emission tomography studies: examples from food sciences. Amino Acids 29: 377-388.
27. HUTCHINS, G.D. 2003. Small animal PET imaging. WSPC/trim size: 9 in x 6 in. Proceedings November 30: 381-390.
28. GOLDSTEIN, D.S., L. CORONADO & I.J. KOPIN. 1994. 6-[Fluorine-18] fluorodopamine pharmacokinetics and dosimetry in humans. J. Nucl. Med. 35: 964-973.
29. CHIRAKAL, R. et al. 1996. Direct radiofluorination of dopamine: 18F-labeled 6-fluorodopamine for imaging cardiac sympathetic innervation in humans using positron emission tomography. Nucl. Med. Biol. 23: 41-45.
30. HOEGERLE, S. et al. 2001. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur. J. Nucl. Med. 28: 64-71.
31. HOEGERLE, S. et al. 2001. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 220: 373-380.
32. OHTA, S. et al. 2005. Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int. J. Cancer 114: 139-143.
33. HUME, S.P., R.N. GUNN & T. JONES. 1998. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur. J. Nucl. Med. 25: 173-176.
34. CHATZIIOANNOU, A.F. 2002. Molecular imaging of small animals with dedicated PET tomographs. Eur. J. Nucl. Med. Mol. Imaging 29: 98-114.
35. MOORE, T.H. et al. 2000. Quantitative assessment of longitudinal metabolic changes in vivo after traumatic brain injury in the adult rat using FDG-microPET. J. Cereb. Blood Flow Metab. 20: 1492-1501.
36. HAYAKAWA, N. et al. 2000. A PET-MRI registration technique for PET studies of the rat brain. Nucl. Med. Biol. 27: 121-125.
37. VAQUERO, J.J. 2001. PET, CT and MRI image registration of the rat brain and skull. IEEE Trans. Nue. Sci. 48: 1440-1445.
38. MARX, J. 2003. Imaging. Animal models: live and in color. Science 302: 1880-1882.
39. SATO, A., B. KLAUNBERG & R. TOLWANI. 2004. In vivo bioluminescence imaging. Comp. Med. 54: 631-634.
40. ZHANG, N. et al. 2005. NF-kappaB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation. J. Biol. Chem. 280: 21400-21408.
41. CONTAG, P.R. et al. 1998. Bioluminescent indicators in living mammals. Nat. Med. 4: 245-247.
42. CHIU, N.H. & T.K. CHRISTOPOULOS. 1999. Two-site expression immunoassay using a firefly luciferase-coding DNA label. Clin. Chem. 45: 1954-1959.